Search
Menu
Home
HTB
2009
February
10
HTB
10 February 2009
Contents
Antiretrovirals
EMEA approves once-daily darunavir/ritonavir (800mg/100mg) for treatment-naive patients in Europe
Treatment access
Lost benefit of ARVs in South Africa
HTB RSS
Early access
UK biobank finds no link between CMV infection and cardiovascular disease: HIV not included in study
25 July 2021
RCT shows no impact of azithromycin in reducing symptoms of mild COVID-19
25 July 2021
Variation in ACE2 levels are not related to outcomes from COVID-19
25 July 2021
IAS 2021: lenacapavir studies show impressive results in naive, extensive drug resistance and potential as PrEP
20 July 2021
All early access reports
Current issues
July 2021
June 2021
May 2021
Back issues
Special report
HTB: no. 5 – plus HIV and COVID-19 (3 May 2021)
3 May 2021
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
